

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.60109677 |
| 2 | central nervous system myelination (GO:0022010) | 8.60109677 |
| 3 | fatty acid elongation (GO:0030497) | 6.10415544 |
| 4 | myelination (GO:0042552) | 5.54668144 |
| 5 | axon ensheathment (GO:0008366) | 5.53052656 |
| 6 | ensheathment of neurons (GO:0007272) | 5.53052656 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.88974881 |
| 8 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.82086732 |
| 9 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.64209047 |
| 10 | * presynaptic membrane organization (GO:0097090) | 4.45218907 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.42977137 |
| 12 | negative regulation of neurotransmitter transport (GO:0051589) | 4.40647702 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.21814066 |
| 14 | auditory behavior (GO:0031223) | 4.04653009 |
| 15 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.01629931 |
| 16 | glycerophospholipid catabolic process (GO:0046475) | 3.91465317 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.90147650 |
| 18 | oligodendrocyte differentiation (GO:0048709) | 3.87449753 |
| 19 | apical protein localization (GO:0045176) | 3.85322840 |
| 20 | establishment of mitochondrion localization (GO:0051654) | 3.81010863 |
| 21 | L-amino acid import (GO:0043092) | 3.77190652 |
| 22 | nucleobase catabolic process (GO:0046113) | 3.75835866 |
| 23 | cell migration in hindbrain (GO:0021535) | 3.72880941 |
| 24 | * presynaptic membrane assembly (GO:0097105) | 3.69825073 |
| 25 | cerebellar granule cell differentiation (GO:0021707) | 3.67064523 |
| 26 | asymmetric protein localization (GO:0008105) | 3.57799640 |
| 27 | myelin maintenance (GO:0043217) | 3.57673120 |
| 28 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.57625320 |
| 29 | cholesterol biosynthetic process (GO:0006695) | 3.54589911 |
| 30 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.53827217 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.52092221 |
| 32 | response to auditory stimulus (GO:0010996) | 3.49507909 |
| 33 | negative regulation of protein localization to cell surface (GO:2000009) | 3.48913311 |
| 34 | neuronal action potential propagation (GO:0019227) | 3.48704249 |
| 35 | exploration behavior (GO:0035640) | 3.48269030 |
| 36 | mechanosensory behavior (GO:0007638) | 3.43882387 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.42653004 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40444705 |
| 39 | sodium ion export (GO:0071436) | 3.38614404 |
| 40 | photoreceptor cell differentiation (GO:0046530) | 3.37985569 |
| 41 | eye photoreceptor cell differentiation (GO:0001754) | 3.37985569 |
| 42 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35368961 |
| 43 | startle response (GO:0001964) | 3.34165965 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 3.32820619 |
| 45 | locomotory exploration behavior (GO:0035641) | 3.31778091 |
| 46 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.31003136 |
| 47 | adult walking behavior (GO:0007628) | 3.28121097 |
| 48 | regulation of collateral sprouting (GO:0048670) | 3.26598422 |
| 49 | astrocyte development (GO:0014002) | 3.25553954 |
| 50 | response to methylmercury (GO:0051597) | 3.24490355 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 3.23255390 |
| 52 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.19385451 |
| 53 | cell communication by electrical coupling (GO:0010644) | 3.18790256 |
| 54 | response to redox state (GO:0051775) | 3.14063173 |
| 55 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.13053879 |
| 56 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.12813267 |
| 57 | neuron recognition (GO:0008038) | 3.12710088 |
| 58 | positive regulation of action potential (GO:0045760) | 3.11783606 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.10583259 |
| 60 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.09683854 |
| 61 | central nervous system neuron axonogenesis (GO:0021955) | 3.09499789 |
| 62 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.08929243 |
| 63 | neurotransmitter secretion (GO:0007269) | 3.08491711 |
| 64 | sterol biosynthetic process (GO:0016126) | 3.05771582 |
| 65 | positive regulation of dendritic spine development (GO:0060999) | 3.03561193 |
| 66 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.03045756 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.02613848 |
| 68 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.02475043 |
| 69 | substantia nigra development (GO:0021762) | 3.02458599 |
| 70 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01151390 |
| 71 | gamma-aminobutyric acid transport (GO:0015812) | 3.00668370 |
| 72 | creatine metabolic process (GO:0006600) | 3.00159585 |
| 73 | establishment of nucleus localization (GO:0040023) | 2.99475890 |
| 74 | regulation of synaptic vesicle transport (GO:1902803) | 2.99228109 |
| 75 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.98954276 |
| 76 | negative regulation of axonogenesis (GO:0050771) | 2.98592898 |
| 77 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.97772056 |
| 78 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96947546 |
| 79 | synapse assembly (GO:0007416) | 2.94722233 |
| 80 | import into cell (GO:0098657) | 2.93342727 |
| 81 | membrane depolarization during action potential (GO:0086010) | 2.92362821 |
| 82 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92069740 |
| 83 | neuronal ion channel clustering (GO:0045161) | 2.91859511 |
| 84 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91840834 |
| 85 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.91523740 |
| 86 | peripheral nervous system axon ensheathment (GO:0032292) | 2.90746661 |
| 87 | myelination in peripheral nervous system (GO:0022011) | 2.90746661 |
| 88 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.84298963 |
| 89 | regulation of synapse assembly (GO:0051963) | 2.83833092 |
| 90 | neuron remodeling (GO:0016322) | 2.83070819 |
| 91 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80161431 |
| 92 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.78792564 |
| 93 | protein localization to synapse (GO:0035418) | 2.78346387 |
| 94 | axonal fasciculation (GO:0007413) | 2.78059064 |
| 95 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.77969544 |
| 96 | glutamate receptor signaling pathway (GO:0007215) | 2.77432712 |
| 97 | synaptic transmission, glutamatergic (GO:0035249) | 2.76875500 |
| 98 | nerve growth factor signaling pathway (GO:0038180) | 2.76089400 |
| 99 | dendritic spine morphogenesis (GO:0060997) | 2.75758729 |
| 100 | negative regulation of dendrite development (GO:2000171) | 2.75195275 |
| 101 | long-term memory (GO:0007616) | 2.74971658 |
| 102 | amino acid import (GO:0043090) | 2.74031533 |
| 103 | regulation of axon guidance (GO:1902667) | 2.73270628 |
| 104 | adhesion of symbiont to host cell (GO:0044650) | 2.72676216 |
| 105 | virion attachment to host cell (GO:0019062) | 2.72676216 |
| 106 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.72524549 |
| 107 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.72134191 |
| 108 | mitochondrion transport along microtubule (GO:0047497) | 2.72134191 |
| 109 | cochlea development (GO:0090102) | 2.72048903 |
| 110 | limb bud formation (GO:0060174) | 2.71989708 |
| 111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.71322580 |
| 112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.71196667 |
| 113 | synapse organization (GO:0050808) | 2.70926462 |
| 114 | glutamate secretion (GO:0014047) | 2.70849091 |
| 115 | isoprenoid biosynthetic process (GO:0008299) | 2.70842488 |
| 116 | cellular sodium ion homeostasis (GO:0006883) | 2.70709689 |
| 117 | neuron-neuron synaptic transmission (GO:0007270) | 2.70250396 |
| 118 | cell communication involved in cardiac conduction (GO:0086065) | 2.69939127 |
| 119 | retinal ganglion cell axon guidance (GO:0031290) | 2.69292902 |
| 120 | cellular response to epinephrine stimulus (GO:0071872) | 2.69076237 |
| 121 | membrane tubulation (GO:0097320) | 2.68880926 |
| 122 | protein palmitoylation (GO:0018345) | 2.67336220 |
| 123 | vocalization behavior (GO:0071625) | 2.66978686 |
| 124 | synaptic vesicle exocytosis (GO:0016079) | 2.66605389 |
| 125 | dendrite morphogenesis (GO:0048813) | 2.66146383 |
| 126 | neuromuscular process controlling balance (GO:0050885) | 2.65193015 |
| 127 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.65131779 |
| 128 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.64790520 |
| 129 | membrane depolarization (GO:0051899) | 2.64284798 |
| 130 | regulation of neurotransmitter secretion (GO:0046928) | 2.62290564 |
| 131 | spinal cord development (GO:0021510) | 2.62204735 |
| 132 | axonogenesis (GO:0007409) | 2.61803407 |
| 133 | negative regulation of axon extension (GO:0030517) | 2.61742778 |
| 134 | magnesium ion transport (GO:0015693) | 2.61480169 |
| 135 | L-phenylalanine catabolic process (GO:0006559) | 2.60929293 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60929293 |
| 137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.60789712 |
| 138 | postsynaptic membrane organization (GO:0001941) | 2.60575403 |
| 139 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.60451793 |
| 140 | very long-chain fatty acid metabolic process (GO:0000038) | 2.60120955 |
| 141 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.58758831 |
| 142 | synaptic vesicle maturation (GO:0016188) | 2.56782763 |
| 143 | positive regulation of synapse assembly (GO:0051965) | 2.55323180 |
| 144 | axon development (GO:0061564) | 2.52876504 |
| 145 | negative regulation of JUN kinase activity (GO:0043508) | 2.52195333 |
| 146 | positive regulation of membrane potential (GO:0045838) | 2.51325749 |
| 147 | amyloid precursor protein metabolic process (GO:0042982) | 2.48451479 |
| 148 | membrane hyperpolarization (GO:0060081) | 2.48256895 |
| 149 | negative regulation of synaptic transmission (GO:0050805) | 2.47436348 |
| 150 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.46970113 |
| 151 | regulation of dendritic spine development (GO:0060998) | 2.46060111 |
| 152 | response to epinephrine (GO:0071871) | 2.42541304 |
| 153 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.42464465 |
| 154 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.41862972 |
| 155 | cyclic nucleotide catabolic process (GO:0009214) | 2.41791084 |
| 156 | dendrite development (GO:0016358) | 2.41467390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.79497120 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.41071715 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62482825 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60290539 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59894620 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47094878 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.32935501 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23966133 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23966133 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22873673 |
| 11 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.18682649 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16071025 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15313348 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13919284 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11679955 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.10875998 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09441820 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00761590 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98818112 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95162862 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94539771 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93740728 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90090373 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84459527 |
| 25 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80727382 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79928173 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79383790 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75662553 |
| 29 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73406085 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70982561 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69292235 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68054521 |
| 33 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.67257345 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63483046 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62306365 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60827967 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60400288 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59659522 |
| 39 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.59536886 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59338766 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58945367 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56710259 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.56262429 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56089806 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.55282390 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54609561 |
| 47 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54426824 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47512641 |
| 49 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46298996 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44689552 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.43016454 |
| 52 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41520206 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41022322 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40713120 |
| 55 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.39148458 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37091912 |
| 57 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.31387288 |
| 58 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29389557 |
| 59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25524050 |
| 60 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22678673 |
| 61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22104954 |
| 62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21805119 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21338338 |
| 64 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.21305935 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21225745 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20791645 |
| 67 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19746720 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18896839 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17755338 |
| 70 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17159989 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16432483 |
| 72 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16336165 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15449779 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15384274 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14471092 |
| 76 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13816849 |
| 77 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.13073784 |
| 78 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12266142 |
| 79 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11289510 |
| 80 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10925943 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10405888 |
| 82 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08753929 |
| 83 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07689753 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07082479 |
| 85 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06968614 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06534027 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06534027 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06273770 |
| 89 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06090062 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05178353 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05148149 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04717421 |
| 93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04235602 |
| 94 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02250710 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01896553 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01432587 |
| 97 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00688233 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00450148 |
| 99 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00286364 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99889970 |
| 101 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99456542 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99329070 |
| 103 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99157324 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98390240 |
| 105 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98254027 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97872465 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97690043 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97215586 |
| 109 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96983780 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96913559 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96913559 |
| 112 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96549819 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96346655 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95650729 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95515821 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95156396 |
| 117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94936859 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94803137 |
| 119 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94466867 |
| 120 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92131254 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92089840 |
| 122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91403698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.73131725 |
| 2 | MP0000920_abnormal_myelination | 4.01570337 |
| 3 | MP0004270_analgesia | 3.73109048 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.44744480 |
| 5 | MP0001486_abnormal_startle_reflex | 2.74093325 |
| 6 | MP0002064_seizures | 2.69232542 |
| 7 | MP0002272_abnormal_nervous_system | 2.69225174 |
| 8 | * MP0003635_abnormal_synaptic_transmissio | 2.55350169 |
| 9 | MP0003690_abnormal_glial_cell | 2.53271935 |
| 10 | MP0009046_muscle_twitch | 2.52147786 |
| 11 | MP0009745_abnormal_behavioral_response | 2.48142672 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.41296783 |
| 13 | MP0005171_absent_coat_pigmentation | 2.33424560 |
| 14 | MP0004885_abnormal_endolymph | 2.30561735 |
| 15 | MP0000778_abnormal_nervous_system | 2.29703114 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.27475000 |
| 17 | MP0004742_abnormal_vestibular_system | 2.24597807 |
| 18 | MP0003329_amyloid_beta_deposits | 2.24197241 |
| 19 | MP0001529_abnormal_vocalization | 2.19834554 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.11395979 |
| 21 | MP0001905_abnormal_dopamine_level | 2.00588244 |
| 22 | MP0004142_abnormal_muscle_tone | 1.98771966 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 1.94120642 |
| 24 | MP0003122_maternal_imprinting | 1.92446094 |
| 25 | * MP0002063_abnormal_learning/memory/cond | 1.91315852 |
| 26 | MP0005409_darkened_coat_color | 1.90810238 |
| 27 | MP0001485_abnormal_pinna_reflex | 1.84771592 |
| 28 | MP0003634_abnormal_glial_cell | 1.80219509 |
| 29 | MP0003136_yellow_coat_color | 1.77698419 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.76333770 |
| 31 | MP0003787_abnormal_imprinting | 1.76103397 |
| 32 | MP0002229_neurodegeneration | 1.70892329 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.67865847 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.65063162 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.54801486 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.51520232 |
| 37 | MP0004924_abnormal_behavior | 1.51520232 |
| 38 | MP0003632_abnormal_nervous_system | 1.48181877 |
| 39 | MP0008569_lethality_at_weaning | 1.45658995 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.43289720 |
| 41 | * MP0002882_abnormal_neuron_morphology | 1.42527941 |
| 42 | * MP0000955_abnormal_spinal_cord | 1.39438684 |
| 43 | MP0003121_genomic_imprinting | 1.36373766 |
| 44 | MP0003631_nervous_system_phenotype | 1.33004472 |
| 45 | * MP0002066_abnormal_motor_capabilities/c | 1.32968953 |
| 46 | MP0001970_abnormal_pain_threshold | 1.32707538 |
| 47 | MP0000462_abnormal_digestive_system | 1.32578909 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.31271548 |
| 49 | MP0004043_abnormal_pH_regulation | 1.30341627 |
| 50 | MP0003633_abnormal_nervous_system | 1.29105709 |
| 51 | MP0002735_abnormal_chemical_nociception | 1.28318076 |
| 52 | MP0002733_abnormal_thermal_nociception | 1.28026189 |
| 53 | MP0004147_increased_porphyrin_level | 1.27893832 |
| 54 | MP0005187_abnormal_penis_morphology | 1.21937383 |
| 55 | MP0003861_abnormal_nervous_system | 1.19788909 |
| 56 | MP0001963_abnormal_hearing_physiology | 1.18833056 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.18729225 |
| 58 | MP0005410_abnormal_fertilization | 1.17894822 |
| 59 | MP0003195_calcinosis | 1.16668628 |
| 60 | MP0000537_abnormal_urethra_morphology | 1.16534356 |
| 61 | MP0002184_abnormal_innervation | 1.15426066 |
| 62 | MP0002736_abnormal_nociception_after | 1.15318970 |
| 63 | MP0005451_abnormal_body_composition | 1.14286018 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.10772852 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.10034259 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.09863793 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.09404887 |
| 68 | MP0000534_abnormal_ureter_morphology | 1.08410996 |
| 69 | * MP0002752_abnormal_somatic_nervous | 1.08213601 |
| 70 | MP0005248_abnormal_Harderian_gland | 1.07903472 |
| 71 | MP0000604_amyloidosis | 1.07374258 |
| 72 | MP0003119_abnormal_digestive_system | 1.05958154 |
| 73 | MP0001188_hyperpigmentation | 1.04715289 |
| 74 | MP0000383_abnormal_hair_follicle | 1.04582091 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.03174511 |
| 76 | MP0001502_abnormal_circadian_rhythm | 1.02371845 |
| 77 | MP0004381_abnormal_hair_follicle | 1.01310042 |
| 78 | MP0001661_extended_life_span | 1.00450896 |
| 79 | MP0002233_abnormal_nose_morphology | 0.99502433 |
| 80 | MP0003938_abnormal_ear_development | 0.99348129 |
| 81 | MP0001299_abnormal_eye_distance/ | 0.98856211 |
| 82 | MP0002152_abnormal_brain_morphology | 0.98363573 |
| 83 | MP0004134_abnormal_chest_morphology | 0.97971219 |
| 84 | MP0002822_catalepsy | 0.97764421 |
| 85 | MP0002751_abnormal_autonomic_nervous | 0.97712667 |
| 86 | MP0001177_atelectasis | 0.95737817 |
| 87 | MP0005646_abnormal_pituitary_gland | 0.95623412 |
| 88 | MP0000566_synostosis | 0.94963150 |
| 89 | MP0001293_anophthalmia | 0.93696339 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.93010075 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.92851131 |
| 92 | MP0001346_abnormal_lacrimal_gland | 0.91882820 |
| 93 | MP0002102_abnormal_ear_morphology | 0.91457320 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.90317556 |
| 95 | MP0004811_abnormal_neuron_physiology | 0.89731588 |
| 96 | MP0005195_abnormal_posterior_eye | 0.89566121 |
| 97 | MP0004133_heterotaxia | 0.89450732 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.88961328 |
| 99 | MP0000747_muscle_weakness | 0.86031985 |
| 100 | MP0000026_abnormal_inner_ear | 0.85414962 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.84744886 |
| 102 | MP0003879_abnormal_hair_cell | 0.83828911 |
| 103 | MP0003385_abnormal_body_wall | 0.83572500 |
| 104 | MP0000049_abnormal_middle_ear | 0.83211089 |
| 105 | MP0003283_abnormal_digestive_organ | 0.81084488 |
| 106 | MP0005499_abnormal_olfactory_system | 0.80046843 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.80046843 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.79471453 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 0.77373687 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.76705832 |
| 111 | MP0001984_abnormal_olfaction | 0.76231563 |
| 112 | MP0002697_abnormal_eye_size | 0.75859965 |
| 113 | * MP0002081_perinatal_lethality | 0.74990807 |
| 114 | MP0002938_white_spotting | 0.74428843 |
| 115 | MP0005253_abnormal_eye_physiology | 0.74012726 |
| 116 | MP0003123_paternal_imprinting | 0.73371075 |
| 117 | MP0000647_abnormal_sebaceous_gland | 0.73138061 |
| 118 | MP0003937_abnormal_limbs/digits/tail_de | 0.72526204 |
| 119 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72498281 |
| 120 | MP0002090_abnormal_vision | 0.69262602 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.68771823 |
| 122 | MP0003806_abnormal_nucleotide_metabolis | 0.68739889 |
| 123 | MP0000579_abnormal_nail_morphology | 0.66987251 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.66043604 |
| 125 | MP0008260_abnormal_autophagy | 0.63578697 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.63352372 |
| 127 | MP0003868_abnormal_feces_composition | 0.62162196 |
| 128 | MP0008874_decreased_physiological_sensi | 0.61107764 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.60243347 |
| 130 | MP0001340_abnormal_eyelid_morphology | 0.58746512 |
| 131 | MP0004085_abnormal_heartbeat | 0.58486773 |
| 132 | * MP0002069_abnormal_eating/drinking_beha | 0.58344055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.04012087 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.04012087 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.45327680 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 4.91589318 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 4.84735746 |
| 6 | Parakeratosis (HP:0001036) | 4.26212264 |
| 7 | Focal motor seizures (HP:0011153) | 4.06872858 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.02968029 |
| 9 | Febrile seizures (HP:0002373) | 3.95191904 |
| 10 | Spastic gait (HP:0002064) | 3.75901002 |
| 11 | Myokymia (HP:0002411) | 3.57181377 |
| 12 | Peripheral hypomyelination (HP:0007182) | 3.45485929 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.45142991 |
| 14 | Scanning speech (HP:0002168) | 3.42808964 |
| 15 | Intention tremor (HP:0002080) | 3.39669392 |
| 16 | Dysmetria (HP:0001310) | 3.36674406 |
| 17 | Hyperventilation (HP:0002883) | 3.36332581 |
| 18 | Termporal pattern (HP:0011008) | 3.26220351 |
| 19 | Insidious onset (HP:0003587) | 3.26220351 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.15272709 |
| 21 | Onion bulb formation (HP:0003383) | 3.12609685 |
| 22 | Retinal dysplasia (HP:0007973) | 3.06311513 |
| 23 | Akinesia (HP:0002304) | 3.05859686 |
| 24 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.96861017 |
| 25 | Cutaneous finger syndactyly (HP:0010554) | 2.95536842 |
| 26 | Ankle clonus (HP:0011448) | 2.93088302 |
| 27 | Alacrima (HP:0000522) | 2.91945266 |
| 28 | Atonic seizures (HP:0010819) | 2.84177266 |
| 29 | Thickened helices (HP:0000391) | 2.83914885 |
| 30 | Focal seizures (HP:0007359) | 2.71115036 |
| 31 | Broad-based gait (HP:0002136) | 2.63366701 |
| 32 | Cutaneous syndactyly (HP:0012725) | 2.62037373 |
| 33 | Vitreoretinal degeneration (HP:0000655) | 2.60346043 |
| 34 | Hemiparesis (HP:0001269) | 2.58534598 |
| 35 | Hepatoblastoma (HP:0002884) | 2.57810813 |
| 36 | Limb dystonia (HP:0002451) | 2.52011765 |
| 37 | Anteriorly placed anus (HP:0001545) | 2.51780659 |
| 38 | Cerebral hypomyelination (HP:0006808) | 2.50174132 |
| 39 | Slow saccadic eye movements (HP:0000514) | 2.48649955 |
| 40 | Abnormal auditory evoked potentials (HP:0006958) | 2.48648588 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.41789031 |
| 42 | Partial agenesis of the corpus callosum (HP:0001338) | 2.35783014 |
| 43 | Clumsiness (HP:0002312) | 2.34272398 |
| 44 | Lower limb muscle weakness (HP:0007340) | 2.33273694 |
| 45 | Decreased lacrimation (HP:0000633) | 2.30990968 |
| 46 | Midline defect of the nose (HP:0004122) | 2.30566247 |
| 47 | Absent speech (HP:0001344) | 2.28741243 |
| 48 | Spastic tetraparesis (HP:0001285) | 2.28142425 |
| 49 | Polyphagia (HP:0002591) | 2.27805021 |
| 50 | Action tremor (HP:0002345) | 2.24784767 |
| 51 | Pheochromocytoma (HP:0002666) | 2.24502869 |
| 52 | Aplasia involving bones of the extremities (HP:0009825) | 2.23970741 |
| 53 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23970741 |
| 54 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23970741 |
| 55 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.23916048 |
| 56 | Short 4th metacarpal (HP:0010044) | 2.23916048 |
| 57 | Abnormality of the labia minora (HP:0012880) | 2.22546759 |
| 58 | Increased serum pyruvate (HP:0003542) | 2.21392586 |
| 59 | Abnormality of glycolysis (HP:0004366) | 2.21392586 |
| 60 | Coronal craniosynostosis (HP:0004440) | 2.20683420 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.20377616 |
| 62 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.19739153 |
| 63 | Dialeptic seizures (HP:0011146) | 2.16872809 |
| 64 | Absent septum pellucidum (HP:0001331) | 2.15442553 |
| 65 | Leukodystrophy (HP:0002415) | 2.15245823 |
| 66 | Spastic paraparesis (HP:0002313) | 2.13632701 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.13061933 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.12790739 |
| 69 | Metabolic alkalosis (HP:0200114) | 2.12045771 |
| 70 | Cerebral hemorrhage (HP:0001342) | 2.11477605 |
| 71 | Increased circulating renin level (HP:0000848) | 2.11422909 |
| 72 | Generalized myoclonic seizures (HP:0002123) | 2.10509475 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.10500186 |
| 74 | Protruding tongue (HP:0010808) | 2.09873603 |
| 75 | Renal hypoplasia (HP:0000089) | 2.06105589 |
| 76 | Dysdiadochokinesis (HP:0002075) | 2.04905426 |
| 77 | Aqueductal stenosis (HP:0002410) | 2.04649850 |
| 78 | Type II lissencephaly (HP:0007260) | 2.04020178 |
| 79 | Autoamputation (HP:0001218) | 2.03445495 |
| 80 | Infantile muscular hypotonia (HP:0008947) | 2.03285251 |
| 81 | Synostosis involving the elbow (HP:0003938) | 2.03264733 |
| 82 | Humeroradial synostosis (HP:0003041) | 2.03264733 |
| 83 | Megalencephaly (HP:0001355) | 2.02973151 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01694972 |
| 85 | Blue irides (HP:0000635) | 2.01459254 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 2.00952474 |
| 87 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.99137253 |
| 88 | Drooling (HP:0002307) | 1.98716108 |
| 89 | Excessive salivation (HP:0003781) | 1.98716108 |
| 90 | Gait imbalance (HP:0002141) | 1.97026973 |
| 91 | Progressive cerebellar ataxia (HP:0002073) | 1.96772846 |
| 92 | Septo-optic dysplasia (HP:0100842) | 1.96588205 |
| 93 | Clonus (HP:0002169) | 1.96150752 |
| 94 | Methylmalonic acidemia (HP:0002912) | 1.95971368 |
| 95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95105633 |
| 96 | Hemiplegia (HP:0002301) | 1.94464353 |
| 97 | Genetic anticipation (HP:0003743) | 1.94366995 |
| 98 | Split foot (HP:0001839) | 1.92102394 |
| 99 | Genital tract atresia (HP:0001827) | 1.91999053 |
| 100 | Absence seizures (HP:0002121) | 1.91970931 |
| 101 | EEG with generalized epileptiform discharges (HP:0011198) | 1.91826609 |
| 102 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91511164 |
| 103 | Preaxial foot polydactyly (HP:0001841) | 1.91472357 |
| 104 | Neuroendocrine neoplasm (HP:0100634) | 1.90970589 |
| 105 | Bronchomalacia (HP:0002780) | 1.90959253 |
| 106 | Hypoplastic pelvis (HP:0008839) | 1.89403117 |
| 107 | Poor eye contact (HP:0000817) | 1.89380214 |
| 108 | Abnormal social behavior (HP:0012433) | 1.89343173 |
| 109 | Impaired social interactions (HP:0000735) | 1.89343173 |
| 110 | Hypsarrhythmia (HP:0002521) | 1.89073256 |
| 111 | Tracheomalacia (HP:0002779) | 1.86768904 |
| 112 | Cupped ear (HP:0000378) | 1.85891550 |
| 113 | Urinary urgency (HP:0000012) | 1.84641575 |
| 114 | Optic nerve hypoplasia (HP:0000609) | 1.83588856 |
| 115 | Widely spaced teeth (HP:0000687) | 1.81151251 |
| 116 | Poor speech (HP:0002465) | 1.80594013 |
| 117 | Buphthalmos (HP:0000557) | 1.79747468 |
| 118 | Abnormality of the 4th metacarpal (HP:0010012) | 1.79164506 |
| 119 | Amblyopia (HP:0000646) | 1.79121638 |
| 120 | Truncal ataxia (HP:0002078) | 1.78620958 |
| 121 | Abnormality of the septum pellucidum (HP:0007375) | 1.78089031 |
| 122 | Hypomagnesemia (HP:0002917) | 1.76843675 |
| 123 | Abnormality of salivation (HP:0100755) | 1.76174681 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 1.76032095 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75834709 |
| 126 | Papillary thyroid carcinoma (HP:0002895) | 1.75121959 |
| 127 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.75053454 |
| 128 | Intellectual disability, moderate (HP:0002342) | 1.74746798 |
| 129 | Generalized tonic-clonic seizures (HP:0002069) | 1.74423744 |
| 130 | Bowel incontinence (HP:0002607) | 1.73929618 |
| 131 | Premature skin wrinkling (HP:0100678) | 1.73851707 |
| 132 | Vaginal atresia (HP:0000148) | 1.73042801 |
| 133 | Turricephaly (HP:0000262) | 1.73037301 |
| 134 | Intestinal atresia (HP:0011100) | 1.71336932 |
| 135 | Stridor (HP:0010307) | 1.71106218 |
| 136 | Status epilepticus (HP:0002133) | 1.71059233 |
| 137 | Progressive inability to walk (HP:0002505) | 1.70427523 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.69207005 |
| 139 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69207005 |
| 140 | Morphological abnormality of the middle ear (HP:0008609) | 1.68366230 |
| 141 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68328127 |
| 142 | Sleep apnea (HP:0010535) | 1.68287698 |
| 143 | Diminished movement (HP:0002374) | 1.68251597 |
| 144 | Hypoplasia of the corpus callosum (HP:0002079) | 1.67890329 |
| 145 | CNS hypomyelination (HP:0003429) | 1.67845189 |
| 146 | Neuronal loss in central nervous system (HP:0002529) | 1.67743345 |
| 147 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.66892560 |
| 148 | Torticollis (HP:0000473) | 1.64111726 |
| 149 | Abnormality of binocular vision (HP:0011514) | 1.62720505 |
| 150 | Diplopia (HP:0000651) | 1.62720505 |
| 151 | Oligodactyly (hands) (HP:0001180) | 1.61335736 |
| 152 | Specific learning disability (HP:0001328) | 1.60807894 |
| 153 | Lissencephaly (HP:0001339) | 1.60778419 |
| 154 | Exotropia (HP:0000577) | 1.57077462 |
| 155 | Anophthalmia (HP:0000528) | 1.56912732 |
| 156 | Partial duplication of thumb phalanx (HP:0009944) | 1.56886150 |
| 157 | Postural instability (HP:0002172) | 1.56081293 |
| 158 | Gastrointestinal atresia (HP:0002589) | 1.55717025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.28843208 |
| 2 | OXSR1 | 4.40163477 |
| 3 | CASK | 3.07539827 |
| 4 | CDK19 | 2.94942929 |
| 5 | TNIK | 2.74798807 |
| 6 | EPHA4 | 2.53656583 |
| 7 | BCR | 2.36946944 |
| 8 | PNCK | 2.17918825 |
| 9 | WNK4 | 2.14691576 |
| 10 | EPHB1 | 2.14192037 |
| 11 | MARK1 | 2.13650378 |
| 12 | PKN1 | 2.12032091 |
| 13 | FGFR2 | 2.09822327 |
| 14 | PRPF4B | 1.95251140 |
| 15 | WNK1 | 1.86396185 |
| 16 | MET | 1.77562262 |
| 17 | PAK6 | 1.75580924 |
| 18 | CSNK1G3 | 1.75505033 |
| 19 | CSNK1A1L | 1.74900623 |
| 20 | NEK6 | 1.65773529 |
| 21 | ICK | 1.61250861 |
| 22 | UHMK1 | 1.56385692 |
| 23 | CSNK1G2 | 1.54113013 |
| 24 | CSNK1G1 | 1.43204228 |
| 25 | PBK | 1.43085598 |
| 26 | NTRK1 | 1.42210358 |
| 27 | CAMK2B | 1.41552058 |
| 28 | LATS2 | 1.39814715 |
| 29 | MAPKAPK5 | 1.39538000 |
| 30 | SGK2 | 1.38975982 |
| 31 | SIK2 | 1.36816201 |
| 32 | NTRK3 | 1.33238407 |
| 33 | EPHB2 | 1.30426579 |
| 34 | SGK223 | 1.28568171 |
| 35 | SGK494 | 1.28568171 |
| 36 | FGR | 1.27495927 |
| 37 | ROCK2 | 1.17398716 |
| 38 | LIMK1 | 1.10576267 |
| 39 | CAMK2D | 1.09434736 |
| 40 | CDK5 | 1.09022171 |
| 41 | MAP3K4 | 1.08933133 |
| 42 | PRKD3 | 1.03444901 |
| 43 | CAMK1G | 1.01187128 |
| 44 | CAMKK1 | 0.99801163 |
| 45 | PINK1 | 0.99397531 |
| 46 | NTRK2 | 0.98753458 |
| 47 | PAK3 | 0.98718919 |
| 48 | CAMK2A | 0.98053943 |
| 49 | MKNK2 | 0.97260072 |
| 50 | CAMK2G | 0.96013770 |
| 51 | EPHA3 | 0.94424549 |
| 52 | FRK | 0.93007449 |
| 53 | MAP2K7 | 0.92118379 |
| 54 | DAPK2 | 0.91449428 |
| 55 | MARK2 | 0.89625338 |
| 56 | CLK1 | 0.87803579 |
| 57 | MAP3K9 | 0.86969958 |
| 58 | TYRO3 | 0.85863557 |
| 59 | CDK14 | 0.84191236 |
| 60 | MAPK13 | 0.83913906 |
| 61 | ERBB4 | 0.81648929 |
| 62 | PHKG2 | 0.80479323 |
| 63 | PHKG1 | 0.80479323 |
| 64 | PKN2 | 0.79396884 |
| 65 | CDK15 | 0.77815724 |
| 66 | SGK3 | 0.77074644 |
| 67 | CCNB1 | 0.76426592 |
| 68 | OBSCN | 0.76405381 |
| 69 | CDK18 | 0.74630979 |
| 70 | LATS1 | 0.74428050 |
| 71 | BMPR1B | 0.73913551 |
| 72 | DYRK2 | 0.72893540 |
| 73 | PRKCQ | 0.71882664 |
| 74 | MINK1 | 0.70297289 |
| 75 | PRKCE | 0.69360786 |
| 76 | CDK11A | 0.68883572 |
| 77 | STK11 | 0.68753787 |
| 78 | CAMKK2 | 0.68245709 |
| 79 | CAMK4 | 0.66406053 |
| 80 | MUSK | 0.66278550 |
| 81 | CAMK1D | 0.66223004 |
| 82 | PDPK1 | 0.64183498 |
| 83 | FGFR1 | 0.62944597 |
| 84 | FES | 0.60437875 |
| 85 | KSR2 | 0.58004866 |
| 86 | STK38L | 0.57967933 |
| 87 | WNK3 | 0.57921417 |
| 88 | AKT3 | 0.57060194 |
| 89 | ARAF | 0.55555503 |
| 90 | PRKG1 | 0.55411296 |
| 91 | FYN | 0.55371179 |
| 92 | MAP4K2 | 0.54714888 |
| 93 | MKNK1 | 0.54313660 |
| 94 | PLK2 | 0.54214961 |
| 95 | MAP3K13 | 0.53716793 |
| 96 | MAPK7 | 0.53461578 |
| 97 | MAPK15 | 0.53347429 |
| 98 | PRKCG | 0.52922356 |
| 99 | IRAK2 | 0.52915659 |
| 100 | PRKCH | 0.52202873 |
| 101 | ERBB2 | 0.52181106 |
| 102 | DYRK1A | 0.51879956 |
| 103 | DMPK | 0.50882080 |
| 104 | RPS6KA3 | 0.49177918 |
| 105 | PRKD1 | 0.48057235 |
| 106 | ROCK1 | 0.47990327 |
| 107 | ERBB3 | 0.47930497 |
| 108 | CSNK1D | 0.47442640 |
| 109 | PDGFRA | 0.47393017 |
| 110 | YES1 | 0.46887332 |
| 111 | MAP2K4 | 0.44959175 |
| 112 | PIK3CA | 0.43772334 |
| 113 | CDK3 | 0.43149791 |
| 114 | PTK2B | 0.42625945 |
| 115 | CSNK1A1 | 0.42360370 |
| 116 | SGK1 | 0.42326413 |
| 117 | BRD4 | 0.42260586 |
| 118 | CSNK1E | 0.41753218 |
| 119 | RET | 0.40547825 |
| 120 | KSR1 | 0.40418164 |
| 121 | MST4 | 0.39927763 |
| 122 | TESK2 | 0.38995706 |
| 123 | PRKACB | 0.38205668 |
| 124 | GRK5 | 0.38008838 |
| 125 | INSRR | 0.37212291 |
| 126 | CAMK1 | 0.35619811 |
| 127 | PDK1 | 0.35526675 |
| 128 | MAP3K10 | 0.35505304 |
| 129 | GSK3B | 0.35039414 |
| 130 | ADRBK2 | 0.32798689 |
| 131 | PRKACA | 0.31629744 |
| 132 | DDR2 | 0.30828610 |
| 133 | MAPK10 | 0.29674429 |
| 134 | GRK7 | 0.29560045 |
| 135 | PRKCZ | 0.29476713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.66219571 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.46430957 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.22504622 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.18482997 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32066581 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21721383 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.21201161 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.20711744 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.00153964 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.99724508 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97413185 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 1.94975457 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.91069251 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84761633 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.79941091 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.67730123 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52951678 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50548152 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.44396934 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43316602 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.42949087 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42890492 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30931785 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.26866736 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.26088308 |
| 26 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.23421713 |
| 27 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.23194348 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19230534 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17694114 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15644676 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15406430 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14245844 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13598805 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10458374 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.09518398 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08586263 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07827018 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07628613 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06452794 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.06434884 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05688714 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00948159 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 0.97135408 |
| 44 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97056447 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95031103 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94436138 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.94400155 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92105822 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92062222 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90441353 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88451513 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88450502 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88279190 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87696775 |
| 55 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87360131 |
| 56 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.85859034 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85558246 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85552025 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85047857 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84386935 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83864841 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82102764 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80763739 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79723865 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78963358 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77635737 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77365819 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76819270 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.76223588 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76064080 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.75901129 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74513192 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74271876 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72816627 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71145342 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70949764 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70459218 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68643799 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.68025990 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.67778238 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67603398 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.67325761 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66842880 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.66771691 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66698295 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66694340 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65936267 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.64601338 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64080336 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63921774 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63331566 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62604265 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62549089 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62413580 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61631678 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59930416 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59189333 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.58895205 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58712127 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57637329 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57420829 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56110543 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55744949 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.55664499 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54561659 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53703115 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53048478 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52301823 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51509542 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51280233 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50344632 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50021971 |
| 113 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49661038 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.48948682 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47849714 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46387689 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46351065 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45146295 |
| 119 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44148855 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43858638 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.42966862 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41751308 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.41739395 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41587936 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40704030 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40638996 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40410768 |
| 128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40176465 |
| 129 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39889173 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38695812 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38096968 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37618876 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.34680669 |
| 134 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34251382 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33709833 |

